Skip to main content
. 2007 Aug 23;110(13):4552–4559. doi: 10.1182/blood-2007-06-093880

Table 1.

Patient demographics

Characteristics No.
Total number of patients 52
KPS, range (median) 70-100 (90)
M:F 30:22
Age, range (median) y 19.5-62 (47.3)
Diseases
    AML CR1 9
        Intermediate* 6
        High risk* 3
    AML CR2 7
    AML CR1 after MDS 5
    ALL CR1 5
    Ph+ 3
    Ph+, mono 7 1
    t(9;17), mono 7 1
    ALL CR2 1
    ALL CR3 or greater 1
    AL, other 3
    CML CP1 4
    CML, advanced 2
    MDS 2
        RA after AML 1
        RAEB-IT 1
    NHL 11
        B cell
            Low 1
            Intermediate 5
            High 4
        T cell 1
    T-PLL 2
Donors
    M → F 11
    M → M 16
    F → M 14
    F → F 11
    Age, range (median), y 14-71 (45)
Grafts
    PBSC 47
    BM 4
    Both 1

CR indicates complete remission; AL, acute leukemia multilineage; CML, chronic myelogenous leukemia; CP, chronic phase; MDS, myelodysplastic syndrome; RA, refractory anemia; RAEB-IT, refractory anemia with excess blasts in transformation; and T-PLL, T-cell prolymphocytic leukemia.

*

By cytogenetics.

HHS Vulnerability Disclosure